The binding of BRD4 to SEs is known to highly upregulate the expression of certain oncogenes like MYC in cancer cells and disruption of this interaction has shown to selectively repress such genes (Chapuy et al., 2013; Hnisz et al., 2013; Lovén et al., 2013). The gene discussed is MYC; the disease is cancer.